ST
OSIR

Spot Trading’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Spot Trading’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,104
Closed -$94K – 4528
2015
Q4 		$94K Buy
+9,104
New +$124K ﹤0.01% 2836
2014
Q4 		– Sell
-26,462
Closed -$333K – 4859
2014
Q3 		$333K Buy
26,462
+25,347
+2,273% +$362K ﹤0.01% 2837
2014
Q2 		$17K Buy
+1,115
New +$16.4K ﹤0.01% 4210

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Spot Trading's OSIR Position: Q1 2016 in Review

Spot Trading sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2016, closing a stake of 9,104 shares — an estimated $94K sold.

Spot Trading first reported a position in OSIR in Q2 2014 and held it in 3 quarters. The position peaked at $333K in Q3 2014. 80 funds tracked by Wall St. Rank hold OSIR as of Q1 2016.

  • Spot Trading reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 9,104 Osiris Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $94K.
  • Spot Trading first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2014 and held it in 3 quarters.
  • Spot Trading's Osiris Therapeutics, Inc. Common Stock position peaked at $333K in Q3 2014.
  • 80 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.